loss of β2-integrin adhesion leads to nuclear deformation and activation of a cPLA2-GADD34 pathway in BMDCs, which at least partly controls their activated phenotype.
First-pass extracted concept
cPLA2-GADD34 pathway
Aliases
cPLA2, GADD34, Ppp1r15, Ppp1r15a
Evidence Snippets
Supporting Sources
Linked Claims
GADD34 is upregulated in datasets associated with loss of β2-integrin adhesion and nuclear deformation.
Growth arrest and DNA damage-inducible protein (GADD34; Ppp1r15) of the unfolded protein responses was also upregulated in both datasets.
Loss of β2-integrin adhesion leads to nuclear deformation and activation of a cPLA2-GADD34 pathway that partly controls the activated phenotype of bone marrow-derived dendritic cells.
Together, our results show that loss of β2-integrin adhesion leads to nuclear deformation and activation of a cPLA2-GADD34 pathway in BMDCs, which at least partly controls their activated phenotype.
cPLA2 controls interleukin-12 production and CD86 expression in β2-integrin adhesion-deficient bone marrow-derived dendritic cells.
Utilizing a cytosolic phospholipase A2 (cPLA2) inhibitor, we show that the nuclear shape sensor cPLA2 controls interleukin-12 production and CD86 expression of β2-integrin adhesion-deficient BMDCs.
The GADD34 pathway is activated in adhesion-deficient bone marrow-derived dendritic cells and is associated with reduced EIF2α phosphorylation.
We further show that the GADD34 pathway is activated in adhesion-deficient BMDCs, as eukaryotic translation initiation factor 2A (EIF2α) phosphorylation is reduced in these cells
cPLA2 inhibition rescues EIF2α phosphorylation in adhesion-deficient bone marrow-derived dendritic cells.
whilst cPLA2 inhibition rescues EIF2α phosphorylation
GADD34 inhibition decreases interleukin-12 production and CD86 expression in β2-integrin-deficient bone marrow-derived dendritic cells, whereas PERK inhibition has no effect.
GADD34 inhibition led to decreased interleukin-12 production and CD86 expression in β2-integrin-deficient BMDCs, whilst inhibition of protein kinase R-like endoplasmic reticulum kinase (the canonical EIF2α kinase) had no effect.